Smith & Wesson Brands experienced a substantial deterioration in profitability with net income declining meaningfully year-over-year alongside reduced revenue and compressed margins.
The company faced significant headwinds with revenue declining 11.4% while net income fell substantially more, indicating severe margin compression and operational challenges. The combination of reduced cash flow generation, lower capital investment, and increased interest expense suggests the company is managing through a difficult operating environment while potentially constraining growth investments.
Smith & Wesson's financial performance weakened considerably, with revenue declining 11.4% to $474.7M and profitability falling substantially more due to margin compression. The company reduced capital expenditures significantly from $90.8M to $21.6M while cash declined meaningfully to $25.2M, though current liabilities also decreased by 31.1%. Inventory levels increased 37.7% despite lower sales, suggesting demand challenges, while higher interest expense and increased R&D spending further pressured profitability.
Capex reduced 76.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Net income declined 66.1% — review whether driven by operations, interest costs, or non-recurring items.
Cash declined 58.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Inventory surged 37.7% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.
R&D investment increased 31.7% — signals commitment to future product development, though near-term margin impact.
Current liabilities reduced — improved short-term financial position and working capital health.
Interest costs rose 21% — monitor debt levels and coverage ratio in rising rate environment.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Revenue softened 11.4% — monitor whether this is cyclical or structural.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →